Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Harrow Inc (HROW)

Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 369,543
  • Shares Outstanding, K 35,363
  • Annual Sales, $ 130,190 K
  • Annual Income, $ -24,410 K
  • 60-Month Beta 0.48
  • Price/Sales 2.95
  • Price/Cash Flow N/A
  • Price/Book 5.41
Trade HROW with:

Options Overview Details

View History
  • Implied Volatility 133.59% ( +12.33%)
  • Historical Volatility 56.05%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 133.59% on 04/22/24
  • IV Low 16.04% on 11/30/23
  • Put/Call Vol Ratio 3.70
  • Today's Volume 709
  • Volume Avg (30-Day) 581
  • Put/Call OI Ratio 3.39
  • Today's Open Interest 7,635
  • Open Int (30-Day) 9,193

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -733.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.28 +3.11%
on 04/19/24
13.72 -22.74%
on 04/01/24
-0.90 (-7.83%)
since 03/22/24
3-Month
9.13 +16.10%
on 02/05/24
13.72 -22.74%
on 04/01/24
+0.83 (+8.50%)
since 01/22/24
52-Week
7.60 +39.47%
on 11/14/23
28.25 -62.48%
on 05/10/23
-14.03 (-56.96%)
since 04/21/23

Most Recent Stories

More News
Stocks Muted as Fed Rate Decision Looms, Micron Earnings on Tap

June S&P 500 E-Mini futures (ESM24) are down -0.07%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as market participants refrained from making big bets ahead of the eagerly awaited...

$SPX : 5,010.60 (+0.87%)
SPY : 499.72 (+0.92%)
$DOWI : 38,239.98 (+0.67%)
DIA : 382.37 (+0.68%)
$IUXX : 17,210.89 (+1.02%)
QQQ : 418.82 (+1.01%)
IP : 34.76 (-1.72%)
JWN : 18.79 (-0.69%)
HD : 336.11 (+0.22%)
SMCI : 717.02 (+0.47%)
AMD : 148.64 (+1.36%)
MRVL : 62.88 (+1.21%)
Why Shares of Harrow Health Are Jumping Wednesday

The company increased guidance, acquired a company, and had a stock sale.

HROW : 10.60 (+1.44%)
Why Shares of Harrow Health Are Slumping Friday

The pharmaceutical company announced first-quarter earnings Thursday afternoon.

HROW : 10.60 (+1.44%)
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 33.33% and 1.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

ESTA : 48.27 (+1.88%)
HROW : 10.60 (+1.44%)
Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?

Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.

HROW : 10.60 (+1.44%)
IKNA : 1.3000 (-2.26%)
SRZN : 9.25 (-1.65%)
IVVD : 2.19 (-4.78%)
Harrow to Launch FDA-Approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the launch of FDA-approved IHEEZO ™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual...

HROW : 10.60 (+1.44%)
Zacks.com featured highlights Arcellx, Harrow Health, PROG, Chipotle Mexican Grill and Meta

Arcellx, Harrow Health, PROG, Chipotle Mexican Grill and Meta have been highlighted in this Screen of The Week article.

CMG : 2,884.25 (+0.53%)
HROW : 10.60 (+1.44%)
PRG : 32.26 (+0.78%)
META : 481.73 (+0.14%)
ACLX : 52.00 (+0.68%)
5 Stocks With Recent Price Strength That Still Have Upside

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are META, CMG, ACLX, HROW and PRG.

CMG : 2,884.25 (+0.53%)
HROW : 10.60 (+1.44%)
PRG : 32.26 (+0.78%)
META : 481.73 (+0.14%)
ACLX : 52.00 (+0.68%)
Use New Analyst Coverage to Find Great Momentum Stocks to Buy in May

One way for investors to find potentially market-beating stocks to buy in May is to search for stocks gaining analyst coverage.

HROW : 10.60 (+1.44%)
Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?

Here is how HCA Healthcare (HCA) and Harrow Health (HROW) have performed compared to their sector so far this year.

HCA : 310.31 (+1.70%)
HROW : 10.60 (+1.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

See More

Key Turning Points

3rd Resistance Point 11.69
2nd Resistance Point 11.46
1st Resistance Point 11.03
Last Price 10.60
1st Support Level 10.37
2nd Support Level 10.14
3rd Support Level 9.71

See More

52-Week High 28.25
Fibonacci 61.8% 20.36
Fibonacci 50% 17.92
Fibonacci 38.2% 15.49
Last Price 10.60
52-Week Low 7.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar